MOKAN Wealth Management’s Gilead Sciences GILD Stock Holding History

MOKAN Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.31M	Buy	10,399 +4,920	+90%	+$648K	0.5%	41
2026 Q1	$763K	Sell	5,479 -357	-6%	-$50K	0.34%	51
2025 Q4	$717K	Sell	5,836 -1,456	-20%	-$177K	0.32%	52
2025 Q3	$809K	Sell	7,292 -12,060	-62%	-$1.37M	0.41%	51
2025 Q2	$2.15M	Buy	19,352 +3,072	+19%	+$327K	1.2%	26
2025 Q1	$1.82M	Sell	16,280 -2,499	-13%	-$258K	1.1%	29
2024 Q4	$1.73M	Buy	+18,779	New	+$1.69M	1.1%	25

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

MOKAN Wealth Management's GILD Position: Q2 2026 in Review

MOKAN Wealth Management increased its Gilead Sciences (GILD) stake by 90% in Q2 2026, buying an estimated $648K and bringing the position to 10,399 shares worth $1.31M. The position accounts for 0.5% of the portfolio, ranked #41.

MOKAN Wealth Management first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.15M in Q2 2025. 1,034 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

MOKAN Wealth Management held 10,399 shares of Gilead Sciences worth $1.31M as of Q2 2026.
MOKAN Wealth Management bought 4,920 Gilead Sciences shares in Q2 2026, an estimated $648K.
Gilead Sciences made up 0.5% of MOKAN Wealth Management's portfolio in Q2 2026, its #41 holding.
MOKAN Wealth Management first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
MOKAN Wealth Management's Gilead Sciences position peaked at $2.15M in Q2 2025.
1,034 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on MOKAN Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.